Merck price target raised to $116 from $113 at Morgan Stanley
Bullish target upgrade from analyst.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish target upgrade from analyst.
What happened, with direct paths to the underlying reporting
Morgan Stanley raises MRK target to $116 from $113; current price $130.40. Upgrade indicates positive upside expectation.
Target: $116
Posted price: $130.4
Analyst firm: Morgan Stanley
Analyst: Terence Flynn
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.